| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Dec 17, 2007 |
SVP, Gen Counsel & Secretary
Trans History: 117
|
SVP, Gen Counsel & Secretary | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 4,562 | -- | 4,562 |
| Dec 17, 2007 |
SVP, Gen Counsel & Secretary
Trans History: 117
|
SVP, Gen Counsel & Secretary | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 45,438 | -- | 45,438 |
| Dec 17, 2007 |
VP, Controller and Asst. Treas
Trans History: 372
|
VP, Controller and Asst. Treas | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 4,562 | -- | 4,562 |
| Dec 17, 2007 |
VP, Controller and Asst. Treas
Trans History: 372
|
VP, Controller and Asst. Treas | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 15,438 | -- | 15,438 |
| Dec 17, 2007 |
SVP, Clinical Development
Trans History: 208
|
SVP, Clinical Development | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 4,562 | -- | 4,562 |
| Dec 17, 2007 |
SVP, Clinical Development
Trans History: 208
|
SVP, Clinical Development | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 25,438 | -- | 25,438 |
| Dec 17, 2007 |
VP, Regul Devel & Clin Safety
Trans History: 288
|
VP, Regul Devel & Clin Safety | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 4,562 | -- | 4,562 |
| Dec 17, 2007 |
VP, Regul Devel & Clin Safety
Trans History: 288
|
VP, Regul Devel & Clin Safety | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 25,438 | -- | 25,438 |
| Dec 17, 2007 |
Director, Chief Exec Officer & President, Ten Percent Owner
Trans History: 442
|
Director, Chief Exec Officer & President, Ten Percent Owner | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 250,000 | -- | 250,000 |
| Dec 17, 2007 |
SVP, Research & Devel Sciences
Trans History: 683
|
SVP, Research & Devel Sciences | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 4,562 | -- | 4,562 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.